SCHEMBL9889146

SCHEMBL9889146

C=CCc1cc(CO[Si](C(C)C)(C(C)C)C(C)C)ccc1OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 2/20 0.41
ALDH1A1 P00352 4/20 0.40
RAB9A P51151 1/20 0.40
ABCB1 P08183 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.38
PTGER1 P34995 1/20 0.38
PTGER4 P35408 1/20 0.38
PTGER3 P43115 1/20 0.38
PTGER2 P43116 1/20 0.38
PTPN1 P18031 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8646503 0.81 TAAR1 (0.44) CCR5ALDH1A1RAB9A
SCHEMBL9889119 0.80 LTA4H (0.48) CCR5ALDH1A1RAB9AABCB1ABCG2
SCHEMBL9889090 0.79 PTGER1 (0.57) PTGER1PTGER4PTGER3PTGER2
SCHEMBL9889142 0.77 GABRA1 (0.47) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL8646501 0.76 CCR5 (0.48) CCR5ALDH1A1RAB9AMEN1KMT2A
SCHEMBL9889116 0.74 PTGER1 (0.44) PTGER1PTGER4PTGER3PTGER2CYP2C9
SCHEMBL9528336 0.74 MRGPRX4 (0.53) ALDH1A1RAB9AMEN1KMT2AL3MBTL1
SCHEMBL11707797 0.74 CCR5 (0.58) CCR5ALDH1A1RAB9APTGER1LMNA
SCHEMBL18169335 0.74 L3MBTL1 (0.48) ALDH1A1ABCB1ABCG2L3MBTL1MAPT
SCHEMBL1315107 0.74 TSHR (0.46) ALDH1A1L3MBTL1MAPTHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150369816-A1 Polypeptide Immobilization UNIV CHICAGO (US) 2015-12-24 US disclosed
US-9074300-B2 Polypeptide immobilization THE UNIVERSITY OF CHICAGO (US) 2015-07-07 US disclosed
US-20120142547-A1 POLYPEPTIDE IMMOBILIZATION THE UNIVERSITY OF CHICAGO 2012-06-07 US disclosed
US-7888055-B2 Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity THE UNIVERSITY OF CHICAGO (US) 2011-02-15 US disclosed
US-20080064606-A1 Polypeptide immobilization THE UNIVERSITY OF CHICAGO 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064606-A1 Polypeptide immobilization QPCTL, SURF4, QPCT CCR5 1693/4885ALDH1A1 4474/4885RAB9A 4208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.